Drug |
Company |
Program |
Description |
|
Bayer Healthcare Pharmaceuticals, Inc. |
Patient Assistance Program |
Financial assistance program for those unable to gain access to therapy |
|
|
Biogen Idec |
Access Program |
Financial assistance program for patients using Avonex, Tecfidera or Tysabri |
|
|
EMD Serono, Inc. and Pfizer, Inc. |
MS LifeLines Access Made Simple
Patient Assistance Program |
For those newly prescribed Rebif or presently taking Rebif therapy
For those with Medicare prescription drug coverage or with private or no insurance |
|
| Aubagio® | Genzyme, A Sanofi Company | MS One to One | Financial assistance qualified patients |
| Extavia® | Novartis Pharmaceuticals Corp. | Patient Support Program | Financial asistance for patients who cannot afford the cost of Extavia treatment and have no private or public insurance coverage. |
|
GilenyaTM |
Novartis Pharmaceuticals Corp. | Patient Assistance Program | Financial assistance for patients who cannot afford the cost of Gilenya treatment and lack insurance. |
|
Teva Neuroscience |
Patient Assistance Program |
A copay assistance program; also assistance for Medicare Part D and free product |
MS Drug
Betaseron® (interferon beta-1b) 250 mcg for SC injection
Company
Bayer Healthcare Pharmaceuticals, Inc.
Program description
The Betaseron Patient Assistance Program provides Betaseron to patients who meet program eligibility criteria and are otherwise unable to gain access to therapy.
Eligibility, exclusions and limitations
Eligibility is based on household income, insurance status and patient residency. Patients will not qualify for the program if they exceed the financial eligibility guidelines, have adequate private insurance coverage or qualify for certain federal or state assistance program (e.g. Medicaid) for Betaseron, reside outside the US, or if they are not being treated by a U.S. physician.
Application process
There is a two-part application. Part one is for the patient or patient advocate to complete regarding patient demographic, insurance and income information. The patient also needs to submit proof of income. Part two is for the health care provider to complete regarding prescriber contact information and prescription. Once the completed forms are received, the application is reviewed, and the patient and provider are notified of a decision within two business days.
More information
Applications may be downloaded at on Betaseron's website or at www.needymeds.org
MS Drug
Avonex® TecfideraTM and Tysabri®
Company
Biogen Idec
Program description
Biogen Idec offers numerous patient assistance programs for new and existing patients. Patient assistance services can range from: co-pay assistance, alternative funding to assist with the cost of therapy and free drug programs.
The Access Program is one of several Biogen Idec patient assistance programs. This program is tailored to address the various needs of patients based on their insurance and financial circumstances.
Additionally, a patient may be referred to an alternative funding source for assistance. Biogen Idec partners will investigate the benefit structure of the patient's insurance plan and will research ways a patient can maximize coverage. They also look into supplemental sources of coverage and funding for treatment, if required. Learn more about all of Biogen Idec's financial assistance options by calling us at 1-800-456-2255.
Eligibility, exclusions and limitations
Patients must be using Avonex or Tysabri on-label indication and be a U.S. resident. Biogen Idec is committed to working with patients with a range of needs and finding optimal solutions.
Application process
Patients should call Biogen Idec at 1-800-456-2255, Monday-Friday, 8:30am-8:00pm ET to explore speak live with a member of the Biogen Idec Patient Services team.
More information
Website link for additional information and application:
www.AVONEX.com
www.TYSABRI.com
MS Drug
Rebif® (interferon beta-1a)
Company
EMD Serono, Inc. and Pfizer Inc
Program description
MS LifeLines Access Made Simple is a program that provides eligible patients with relapsing forms of MS co-pay and free drug assistance to help with affordability and access to Rebif. As part of MS LifeLines Access Made Simple, a new $0 co-pay program is now available.
Eligibility, exclusions and limitations
Patients who are U.S. residents with relapsing forms of MS, who have either been newly prescribed Rebif or are presently on Rebif therapy, are eligible for MS LifeLines Access Made Simple unless they are covered by federal or state healthcare programs. People currently on Rebif therapy can call MS LIfeLines to determine their eligibility for the new $0 co-pay program. Eligible people taking Rebif, who are currently receiving co-pay assistance under the MS LifeLines Access Made Simple program will be automatically enrolled in the $0 co-pay program by April 1, 2014. For people who are not eligible for the $0 co-pay program, MS LifeLines offers Financial Support Team members who will help them explore options to find affordable access to Rebif.
Application process
There is no enrollment process; patients are automatically enrolled when they follow standard procedures already in place for voluntary enrollment in MS LifeLines support services.
More information
Please visit www.mslifelines.com or call 1-877-44-REBIF (1-877-447-3243).
MS Drug
Extavia®
Company
Novartis Pharmaceuticals Corp.
Program description
For patients who cannot afford the cost of Extavia treatment and have no private or public insurance coverage, the patient or physician may call the support program at 1-866-925-2333.
Eligibility, exclusions and limitations
The Extavia Patient Support Program provides assistance to patients experiencing financial hardship who have no third- party insurance coverage for their medicines. Patient must be a U.S. Resident. Patient must not have prescription drug coverage (public or private). Patient must meet income eligiblity criteria, which vary by household size and product.
More information
Please call the Extavia Patient Support Program at 1-866-925-2333 or visit their website www.extavia.com.
MS Drug
Copaxone®
Company
Teva Neuroscience
Program description
A copay assistance program is available through Shared Solutions for those who qualify. There is also assistance for Medicare Part D and free product for those who qualify.
Eligibility, exclusions and limitations
For the Private Copay Program the patient must not receive coverage from any federal or state government assistance program, including but not limited to Medicare, Medicaid, TRICARE or a PACE program. There are also a few states that prohibit us from providing assistance to their residents.
Application process
An application will need to be completed and if you have insurance please have that information readily available.
More information
Call Shared Solutions at 1-800-887-8100. You will be put in touch with a benefits investigator.
MS Drug
Gilenya™
Company
Novartis Pharmaceuticals
Program Description
For patients who cannot afford the cost of Gilenya™ treatment and lack insurance, the Patient/Physician may call the Gilenya Support Program at 1-877-408-4974.
Eligibility, exclusions and limitations
Provides assistance to patients experiencing financial hardship who have no third party insurance coverage for their medicines. To be eligible for Novartis PAF, patients must: be a U.S resident, provide proof of income within the program guidelines, and not have private or public prescription coverage.
Application Process
For patients who cannot afford the cost of Gilenya™ treatment and lack insurance, the Patient/Physician may call the Gilenya Support Program at 1-877-408-4974.
More Information
Please call Gilenya Support Gilenya Support Program at 1-877-408-4974 or visit their website.